Efficacy of Minocycline for the Treatment of Mycoplasma genitalium
Open Forum Infectious Diseases · 01.08.2023 · 10 (8)
DOI: 10.1093/ofid/ofad427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 11.08.2023. Verfasst von Emily J Clarke und 7 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian National Health and Medical Research Council (NHMRC) Leadership Investigator, NHMRC Emerging Leadership Investigator.
Abstract (Originalsprache)
Background
High levels of macrolide resistance and increasing fluoroquinolone resistance are making Mycoplasma genitalium increasingly difficult to treat. Minocycline is an alternative treatment for patients with macrolide-resistant M genitalium infections that have failed moxifloxacin, or for those with fluoroquinolone contraindications or resistance. Published efficacy data for minocycline for M genitalium are limited.
Methods
We evaluated minocycline 100 mg twice daily for 14 days at Melbourne Sexual Health Centre (MSHC). Microbial cure was defined as a negative test of cure within 14–90 days after completing minocycline. The proportion cured and 95% confidence intervals (CIs) were calculated, and logistic regression was used to explore factors associated with treatment failure. We pooled data from the current study with a prior adjacent case series of patients with M genitalium who had received minocycline 100 mg twice daily for 14 days at MSHC.
Results
Minocycline cured 60 of 90 (67% [95% CI, 56%–76%]) infections. Adherence was high (96%) and side effects were mild and self-limiting. No demographic or clinical characteristics were associated with minocycline failure in regression analyses. In the pooled analyses of 123 patients, 83 (68% [95% CI, 58%–76%]) were cured following minocycline.
Conclusions
Minocycline cured 68% of macrolide-resistant M genitalium infections. These data provide tighter precision around the efficacy of minocycline for macrolide-resistant M genitalium and show that it is a well-tolerated regimen. With high levels of macrolide resistance, increasing fluoroquinolone resistance, and the high cost of moxifloxacin, access to nonquinolone options such as minocycline is increasingly important for the clinical management of M genitalium.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.
- Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, Alfred Hospital, Alfred Health, Melbourne, Victoria, Australia.
ORCID-Profile: Emily J Clarke, Lenka A Vodstrcil, Erica L Plummer, Ranjit S Samra, Catriona S Bradshaw
Förderung
- Australian National Health and Medical Research Council (NHMRC) Leadership Investigator
- NHMRC Emerging Leadership Investigator
Zitieren
APA
Clarke, E. J., Vodstrcil, L. A., Plummer, E. L., Aguirre, I., Samra, R. S., Fairley, C. K., Chow, E. P. F., & Bradshaw, C. S. (2023). Efficacy of Minocycline for the Treatment of Mycoplasma genitalium. Open Forum Infectious Diseases, 10(8). https://doi.org/10.1093/ofid/ofad427
Vancouver
Clarke EJ, Vodstrcil LA, Plummer EL, Aguirre I, Samra RS, Fairley CK, et al. Efficacy of Minocycline for the Treatment of Mycoplasma genitalium. Open Forum Infectious Diseases. 2023;10(8). doi:10.1093/ofid/ofad427
BibTeX
@article{Clarke2023,
author = {Clarke, Emily J and Vodstrcil, Lenka A and Plummer, Erica L and Aguirre, Ivette and Samra, Ranjit S and Fairley, Christopher K and Chow, Eric P F and Bradshaw, Catriona S},
title = {Efficacy of Minocycline for the Treatment of Mycoplasma genitalium},
journal = {Open Forum Infectious Diseases},
year = {2023},
volume = {10},
number = {8},
doi = {10.1093/ofid/ofad427}
}
EUVIMED